Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
309 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
Cell death mystery yields new suspect for cancer drug development
by Mary Ruth published Sep 13, 2012 last modified Sep 18, 2012 02:55 PM — filed under: ,
Chapel Hill, NC – A mysterious form of cell death, coded in proteins and enzymes, led to a discovery by UNC researchers uncovering a prime suspect for new cancer drug development.
Located in News / 2012 News
Channing Der and Yue Xiong receive 2011 Battle Distinguished Cancer Research Award
by Mary Ruth published Jul 12, 2011 last modified Jul 15, 2011 10:52 AM — filed under: , ,
Chapel Hill - Channing Der, PhD, Kenan Professor of Pharmacology, and Yue Xiong, PhD, Kenan Professor of Biochemistry and Biophysics, have been awarded the fourth annual Hyman L. Battle Distinguished Cancer Research Award in recognition of their accomplishments in cancer research. Both are members of UNC Lineberger Comprehensive Cancer Center.
Located in News / 2011 News
Chapel Hill, Carrboro turning pink to support UNC cancer patients and families
by Mary Ruth published Oct 01, 2012 last modified Oct 01, 2012 09:21 AM — filed under: , ,
Chapel Hill, NC – More than 50 Chapel Hill and Carrboro businesses and community groups are turning the towns pink during the months of September and October to raise funds for UNC Lineberger Comprehensive Cancer Center and its Comprehensive Cancer Support Program.
Located in News / 2012 News
Charles Perou, PhD, appointed May Goldman Shaw Distinguished Professorship of Molecular Oncology Research
by Mary Ruth published Aug 16, 2011 last modified Aug 16, 2011 10:37 AM — filed under: , ,
Chapel Hill, NC – Charles M. Perou, PhD, professor of genetics, and pathology & laboratory medicine, and leader of the UNC Lineberger Comprehensive Cancer Center breast cancer research program has been appointed the May Goldman Shaw Distinguished Professor of Molecular Oncology Research. The professorship, established by a $1 million gift from Wally (class of ’66) and Lil Loewenbaum of Austin, Texas is named in honor of Mrs. Lowenbaum’s mother, May Goldman Shaw.
Located in News / 2011 News
Chase Jones pitches Basebald for the Cure to teams across the country
by Mary Ruth published Jan 13, 2012 last modified Jan 13, 2012 09:54 AM — filed under: ,
When Chase Jones organized Basebald for the Cure, he hit a home run!
Located in News / 2012 News
Chemist receives NIH award to support innovative research
by Mary Ruth published Sep 16, 2011 last modified Sep 16, 2011 04:07 PM — filed under: , ,
Kevin Weeks, a chemist at the University of North Carolina at Chapel Hill, has received an award from the National Institutes of Health to support innovative research on creating new drugs that work by binding to RNA.
Located in News / 2011 News
Chen presents prostate study abstract at American Society of Clinical Oncology symposium
by Mary Ruth published Feb 01, 2012 last modified Feb 01, 2012 03:55 PM — filed under: , ,
Located in News / 2012 News
Clinical trial of experimental drug targeting mutation in thyroid cancer shows clinical benefit
by Mary Ruth published Apr 02, 2012 last modified Apr 02, 2012 04:42 PM — filed under: , ,
Chapel Hill - In a clinical trial of an experimental drug to treat thyroid cancer, UNC and six other institutions report the first evidence in this tumor that targeting therapy to an oncogene documented to be present in the patient receiving therapy may be associated with clinical benefit.
Located in News / 2012 News
Combination therapy beneficial for head and neck skin carcinomas, UNC study shows
by Mary Ruth published Oct 04, 2011 last modified Oct 12, 2011 08:54 AM — filed under: ,
CHAPEL HILL, N.C. - Patients who have high-risk non-melanoma skin carcinomas of the head and neck may benefit from concomitant radiotherapy and chemotherapy, according to a UNC-led study. Their study is the first to report on multiple patients with these skin carcinomas treated simultaneously with radio-and chemotherapy.
Located in News / 2011 News
Combination therapy for triple-negative breast cancer disappointing
by Mary Ruth published Jun 12, 2012 last modified Jun 12, 2012 09:31 AM — filed under: , ,
CHAPEL HILL, N.C. – A recent clinical trial testing a combination therapy for basal-like (also known as triple-negative) breast cancer demonstrates that a combination of two drugs with promising preclinical results is not as effective as researchers had hoped.
Located in News / 2012 News